Biotechnology Axsome Therapeutics Completes U.S. Acquisition of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea May 9, 2022
Biotechnology Allogene Therapeutics Named 2022 Bay Area “Best Place to Work” by San Francisco Business Times and Silicon Valley Business Journal May 9, 2022
Biotechnology Biohaven to Discuss First Quarter 2022 Financial Results and Recent Business Developments on May 11, 2022 May 9, 2022
Biotechnology Alkermes Announces Four Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting May 9, 2022
Biotechnology Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi® (solriamfetol) to Axsome Therapeutics May 9, 2022
Search
biotech stock market
